Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

類似資料

• Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin.
  著者:: Eil, C, 等
  出版事項: (1981)
• Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
  著者:: Cundy, T, 等
  出版事項: (1982)
• Failure to heal vitamin D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
  著者:: Gillies, D R, 等
  出版事項: (1982)
• Effect of 1,25-dihydroxy-vitamin D(3) in experimental sepsis
  著者:: Møller, Søren, 等
  出版事項: (2007)
• Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis.
  著者:: Memmos, D E, 等
  出版事項: (1981)